HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jeffrey A Cadeddu Selected Research

Solitary Kidney

1/2020Re: A Multi-Institutional Report of Peri-Operative and Functional Outcomes after Robot-Assisted Partial Nephrectomy in Patients with a Solitary Kidney.
8/2016Comparative Effects of Irreversible Electroporation, Radiofrequency Ablation, and Partial Nephrectomy on Renal Function Preservation in a Porcine Solitary Kidney Model.
5/2015Ineffectiveness of remote ischemic renal preconditioning in a porcine solitary-kidney model.
7/2012Re: Tumour in solitary kidney: laparoscopic partial nephrectomy vs laparoscopic cryoablation.
6/2012Tadalafil for prevention of renal dysfunction secondary to renal ischemia.
10/2011Minimal arterial in-flow protects renal oxygenation and function during porcine partial nephrectomy: confirmation by hyperspectral imaging.
2/2010Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques.
10/2009Comparison of tissue oxygenation profiles using 3 different methods of vascular control during porcine partial nephrectomy.
4/2008Radiofrequency ablation for T1a tumors in a solitary kidney: promising intermediate oncologic and renal function outcomes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jeffrey A Cadeddu Research Topics

Disease

68Neoplasms (Cancer)
01/2022 - 08/2002
30Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 11/2002
13Prostatic Neoplasms (Prostate Cancer)
12/2019 - 03/2004
10Hemorrhage
01/2021 - 06/2002
9Solitary Kidney
01/2020 - 04/2008
7Margins of Excision
11/2020 - 06/2004
5Kidney Neoplasms (Kidney Cancer)
01/2016 - 01/2007
5Ischemia
05/2015 - 02/2007
4Neoplasm Metastasis (Metastasis)
12/2019 - 03/2004
4Pain (Aches)
01/2017 - 12/2005
4Intraoperative Complications
06/2015 - 06/2012
3Thrombosis (Thrombus)
01/2022 - 01/2016
3Adenoma (Adenomas)
01/2020 - 05/2016
3Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2019 - 05/2014
3Testicular Neoplasms (Testicular Cancer)
01/2017 - 11/2002
3Carcinoma (Carcinomatosis)
10/2016 - 01/2014
3Reperfusion Injury
04/2013 - 06/2012
3Postoperative Pain
03/2012 - 08/2003
3Shock
06/2005 - 04/2002
2Pneumoperitoneum
01/2020 - 12/2007
2Adenocarcinoma
10/2019 - 08/2019
2Flank Pain
01/2019 - 12/2014
2Angiomyolipoma
07/2012 - 11/2006
2Necrosis
01/2011 - 06/2008
2Renal Insufficiency (Renal Failure)
03/2010 - 04/2008
2Convalescence
05/2009 - 08/2003
2Extranodal Extension
01/2007 - 06/2004
2Wounds and Injuries (Trauma)
11/2005 - 09/2003
1Inflammation (Inflammations)
01/2021
1Venous Thromboembolism
01/2021
1Ileus
01/2020
1Vesicovaginal Fistula
01/2019
1Stress Urinary Incontinence
01/2019
1Ureteral Obstruction
01/2019
1Lung Neoplasms (Lung Cancer)
11/2018
1Disease Progression
08/2017
1Suppuration
10/2016
1Urinary Bladder Neoplasms (Bladder Cancer)
05/2016
1Urinary Incontinence
02/2016
1Erectile Dysfunction
02/2016
1Urinary Fistula
01/2016

Drug/Important Bio-Agent (IBA)

5CreatinineIBA
11/2017 - 09/2003
5Hemostatics (Antihemorrhagics)IBA
01/2017 - 06/2002
4Prostate-Specific Antigen (Semenogelase)IBA
01/2007 - 03/2004
3Glucose (Dextrose)FDA LinkGeneric
11/2018 - 11/2005
3NAD (NADH)IBA
06/2011 - 11/2006
3Eosine Yellowish-(YS) (Eosin)IBA
01/2011 - 11/2006
3Hematoxylin (Haematoxylon)IBA
01/2011 - 11/2006
2LipidsIBA
08/2017 - 12/2015
2Narcotics (Narcotic Analgesics)IBA
01/2017 - 06/2007
2A-factor (Streptomyces)IBA
01/2017 - 11/2005
2Morphine (MS Contin)FDA LinkGeneric
09/2013 - 12/2005
2Hemoglobins (Hemoglobin)IBA
10/2011 - 08/2011
2Coloring Agents (Dyes)IBA
01/2011 - 11/2006
2GoldIBA
02/2008 - 08/2007
1RNA (Ribonucleic Acid)IBA
01/2021
1Enoxaparin (Lovenox)FDA LinkGeneric
01/2021
1AldosteroneIBA
01/2020
1Tricarboxylic AcidsIBA
11/2018
1IsotopesIBA
11/2018
1CarbohydratesIBA
11/2018
1Biomarkers (Surrogate Marker)IBA
08/2017
1CholesterolIBA
08/2017
1Nonesterified Fatty Acids (NEFA)IBA
08/2017
1Phospholipids (Phosphatides)FDA LinkGeneric
08/2017
1Triglycerides (Triacylglycerol)IBA
08/2017
1SuspensionsIBA
10/2016
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2015
1DiureticsIBA
12/2014
1Analgesics (Analgesic Drugs)IBA
09/2013

Therapy/Procedure

51Nephrectomy
01/2022 - 11/2002
42Radiofrequency Ablation
01/2020 - 07/2002
16Prostatectomy (Retropubic Prostatectomy)
01/2020 - 03/2004
14Cryosurgery
01/2019 - 09/2004
13Therapeutics
01/2021 - 06/2005
7Lymph Node Excision (Lymph Node Dissection)
01/2018 - 11/2002
6Lasers (Laser)
12/2018 - 06/2002
6Length of Stay
11/2011 - 11/2002
5Operative Time
06/2015 - 11/2002
4Ablation Techniques
11/2021 - 07/2004
4Warm Ischemia
01/2021 - 03/2010
4Lithotripsy (Extracorporeal Shockwave Lithotripsy)
06/2005 - 04/2002
3Hysterectomy
01/2019 - 03/2012
3Aftercare (After-Treatment)
07/2010 - 01/2003
2Radiotherapy
12/2019 - 03/2004
2Stents
01/2019 - 09/2018
2Nephroureterectomy
10/2016 - 01/2014
2Sutures (Suture)
03/2012 - 04/2006
1Precision Medicine
11/2021
1Immunotherapy
01/2021
1Artificial Urinary Sphincter
01/2019
1Replantation
01/2019
1Morcellation
12/2018
1Perioperative Period
01/2017
1Catheters
10/2016
1Cystectomy
05/2016
1Laser Therapy (Surgery, Laser)
01/2016
1Optical Fibers
03/2015
1Computer-Assisted Surgery (Image Guided Surgery)
05/2014
1Conversion to Open Surgery
08/2013